Letter: is there a role for infliximab biosimilar in patients with inflammatory bowel disease with secondary loss of response to infliximab innovator?

Alimentary Pharmacology&Therapeutics,Volume 48, Issue 9, Page 1037-1038, November 2018.

Source: Alimentary Pharmacology and Therapeutics - October 15, 2018 Category: Drugs & Pharmacology Authors: Eleni Orfanoudaki, Ioannis Drygiannakis, Ioannis E. Koutroubakis Source Type: research